Gaudium IVF And Women Health Limited
ListedMainboardHealthcare · NSE / BSE
Founded in March 2015, Gaudium IVF and Women Health Limited specializes in In Vitro Fertilization (IVF) and women’s healthcare services across India, operating through a hub-and-spoke model with seven hubs and twenty-eight spokes. The company collaborates with Infertility Experts to promote awareness of Assisted Reproductive Technology (ART) and IVF treatments. Serving patients from countries like Canada, the UK, the USA, Kenya, South Africa, and Oman, Gaudium has centres in key cities such as Delhi, Mumbai, Ludhiana, Srinagar, Patna, and Bangalore. It offers advanced fertility treatments including IVF, ICSI, IUI, ovulation induction, and male infertility solutions, along with specialized care for PCOD/PCOS, endometriosis, and high-risk pregnancies.
Price Band
₹75 – ₹79
Issue Size
₹2088.62 L Cr
Lot Size
189 shares
GMP
₹2
-2.5%
Est. Listing
₹77
at current GMP
Subscribed
7.27x
overall
Open
20 Feb 2026
Close
24 Feb 2026
Allotment
25 Feb 2026
Refund
26 Feb 2026
Demat Credit
27 Feb 2026
Listing
27 Feb 2026
Last updated 7 months ago
Live Grey Market Premium
Gaudium IVF And Women Health Limited GMP Today
Last updated: 27 Feb 2026
Current Premium
₹-2-2.5%
Issue Price (Upper)
₹79
Band: ₹75 – ₹79
Estimated Listing Price
₹77
Upper price + GMP
Lot Size
189 shares
Min investment ₹14,931
Estimated Profit / Lot
₹0
189 × ₹-2
Gaudium IVF And Women Health Limited GMP Historical Trend
GMP History
Grey Market Premium trend
-₹2
▲ 0 today
Updated 1 minute ago
Estimated Listing Price
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 28 Sep 2026 | -₹2 | -2.5% | ₹77 |
| 26 Sep 2026 | -₹2 | -2.5% | ₹77 |
| 25 Sep 2026 | — | -2.3% | ₹77 |
GMP is unofficial market data. Not a guarantee of listing performance.
About Gaudium IVF And Women Health Limited Public Issue & Market Profile
Gaudium IVF And Women Health Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹2,08,86,200 Crores. The shares are offered at a price band of ₹75 to ₹79 per equity share on NSE and BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Public Issue & Pricing Context:
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 189 shares (approx. ₹14,931 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Basis of Allotment & Listing Timeline:
Allotment reconciliation will be managed by Bigshare Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2026-02-27, while un-allotted funds or UPI block mandates will be released on 2026-02-26.
Frequently Asked Questions
What is Gaudium IVF And Women Health Limited IPO GMP today?
The latest grey market premium for Gaudium IVF And Women Health Limited IPO is ₹-2, which indicates an expected listing price of ₹77.
What does Kostak Rate and Sauda mean in IPO GMP?
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
Is Grey Market Premium officially recognized?
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.